Solitaire Healthcare Consultancy
Helping health tech founders and leadership teams monetise their solution, build their commercial model, and achieve scalable growth across Ireland, the UK, and European markets.
Start a conversationThe proposition
The right commercial strategy. The right market entry approach. The right relationships opened at the right time.
Solitaire Healthcare Consultancy exists to close that gap — bringing 30 years of senior commercial leadership in diagnostics, oncology, digital health, and molecular solutions to bear on your most important commercial challenges.
Founded by Paul Weldon, Solitaire works with health tech founders, scaling businesses, and multinational organisations seeking to establish or expand their presence in the Irish and UK healthcare markets.
What we do
From market entry strategy to fractional commercial leadership, Solitaire delivers the expertise that turns healthcare innovation into sustainable commercial growth.
i.
Strategic analysis and roadmapping for US and international health tech companies entering the Irish and UK markets. Clinical landscape, regulatory pathways, reimbursement strategy, and stakeholder mapping.
ii.
Senior commercial director capability on a fractional basis — go-to-market strategy, team leadership, pipeline development, and partnership negotiation without the cost of a full-time executive hire.
iii.
End-to-end commercial model design for health tech founders — pricing, positioning, channel strategy, and scalable growth frameworks tailored to the Irish and UK healthcare ecosystem.
iv.
Navigation of HSE, NHS, and EMEA reimbursement pathways. Evidence strategy, health economics frameworks, and stakeholder engagement with payers, procurement, and policy influencers.
v.
Identification and structuring of commercial partnerships with pharma, medtech, and MNC organisations. Ecosystem mapping, deal negotiation, and relationship activation at senior level.
vi.
Deep relationships across Irish and UK clinical networks — pathology, oncology, genomics, and hospital leadership. Connecting health tech solutions with the right clinical champions and decision makers.
Paul Weldon

Paul Weldon — Founder, Solitaire Healthcare Consultancy
Paul Weldon is one of Ireland's most experienced commercial healthcare executives, with over 30 years of leadership spanning diagnostics, oncology, digital pathology, molecular solutions, and SaaS-enabled healthcare platforms.
His career has been defined by building things — transitioning markets, launching platforms, and leading teams through complex commercial transformation at Roche, Siemens, and Bayer across Ireland, the UK, and EMEA.
Paul founded Solitaire Healthcare Consultancy to bring that depth of experience directly to health tech founders and leadership teams who need a commercial partner who has been in the room with the buyers they are trying to reach.
Sector expertise
Tissue diagnostics, molecular diagnostics, digital pathology, and clinical sequencing. Deep commercial and clinical relationships across Irish and UK laboratory networks.
Pharma and diagnostics commercialisation across the oncology pathway — companion diagnostics, biomarker platforms, immunotherapy, and tumour board solutions.
SaaS platform commercialisation, digital oncology solutions, AI-enabled health tech, and clinical decision support tools across Irish and UK healthcare systems.
Next generation sequencing access strategy, NHS Genomic Test Directory navigation, Genomic Laboratory Hub relationships, and personalised healthcare commercialisation.
Get in touch
Whether you're entering the Irish market for the first time or scaling an existing commercial operation, Solitaire brings the relationships and expertise to accelerate your journey.
paul.weldon@solitaire-health.comIreland · United Kingdom · Europe